Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
Go back to Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data| (NASDAQ: BNTX) | Delayed: 89.67 -1.62 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.29 | 52 Week High | $ | |||
| Open | $90.75 | 52 Week Low | $ | |||
| Day High | $92.73 | P/E | N/A | |||
| Day Low | $89.03 | EPS | $ | |||
| Volume | 1,164,449 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.42 +0.57 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.85 | 52 Week High | $37.39 | |||
| Open | $30.05 | 52 Week Low | $28.25 | |||
| Day High | $30.44 | P/E | 18.44 | |||
| Day Low | $29.88 | EPS | $1.65 | |||
| Volume | 28,697,226 | |||||



